Last reviewed · How we verify

Placebo / Botulinum Toxin A — Competitive Intelligence Brief

Placebo / Botulinum Toxin A (Placebo / Botulinum Toxin A) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neurotoxin / Acetylcholine release inhibitor. Area: Neurology / Dermatology / Aesthetics.

marketed Neurotoxin / Acetylcholine release inhibitor SNAP-25 (synaptosome-associated protein of 25 kDa) Neurology / Dermatology / Aesthetics Small molecule Live · refreshed every 30 min

Target snapshot

Placebo / Botulinum Toxin A (Placebo / Botulinum Toxin A) — Walter Reed Army Medical Center. Botulinum toxin A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Placebo / Botulinum Toxin A TARGET Placebo / Botulinum Toxin A Walter Reed Army Medical Center marketed Neurotoxin / Acetylcholine release inhibitor SNAP-25 (synaptosome-associated protein of 25 kDa)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neurotoxin / Acetylcholine release inhibitor class)

  1. Walter Reed Army Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo / Botulinum Toxin A — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-botulinum-toxin-a. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: